ResistAid® (Larch Arabinogalactan — Lonza)

Larix occidentalis
Evidence Level
Strong
3 Clinical Trials
6 Documented Benefits
4/5 Evidence Score

ResistAid® is a standardized larch arabinogalactan ingredient developed by Lonza — sustainably-sourced from North American larch trees (Larix occidentalis) using a water-based extraction method. Distinguished by clinical evidence for immune support including reduced cold/flu incidence, gut microbiome modulation, and prebiotic effects. Used for: immune system support, gut health, prebiotic fiber, antibody response enhancement.

Studied Dose 1.5-4.5 g/day ResistAid (research-validated)
Active Compound Arabinogalactan polysaccharide from Larix occidentalis larch

Benefits

Cold and Flu Incidence Reduction

Multiple ResistAid RCTs show reduced incidence of cold and flu symptoms in healthy adults. Riede 2013 (Curr Med Res Opin) showed 23% fewer cold episodes in ResistAid group vs placebo.

Antibody Response Enhancement

ResistAid shown to enhance antibody response to vaccination (pneumococcal vaccine response improved); supports adaptive immune function.

Gut Microbiome Modulation

Recent studies show ResistAid positively modulates gut microbiome — increases beneficial bacteria (Bifidobacterium, Lactobacillus); prebiotic effect.

NK Cell Activity Enhancement

Activates natural killer cells — first-line innate immunity defense against viruses and abnormal cells.

Sustainable Larch Source

Larch arabinogalactan extracted from sustainably-sourced North American larch chips using water-based extraction (no chemical solvents). Clean-label positioning.

Soluble Fiber / Prebiotic

ResistAid is a soluble fiber that bypasses upper GI digestion; fermented in colon by beneficial bacteria producing short-chain fatty acids (especially butyrate).

Mechanism of action

1

Innate Immune Activation

Arabinogalactan binds to immune cell receptors; activates macrophages, dendritic cells, NK cells; enhances first-line immune response.

2

Adaptive Immune Support

ResistAid enhances B-cell antibody production — improved adaptive immune response to pathogens and vaccines.

3

Prebiotic Fermentation

Soluble fiber resists upper GI digestion; fermented in colon by beneficial bacteria; produces short-chain fatty acids supporting gut barrier and gut-immune axis.

4

Gut Microbiome Modulation

Selective stimulation of beneficial bacteria (Bifidobacterium, Lactobacillus); shifts microbiome composition toward healthier profile.

5

Larch Source Distinction

Larch arabinogalactan distinct from acacia gum arabic — different polysaccharide structure; specific immune evidence base.

Clinical trials

1
ResistAid for Cold Incidence

Clinical trial of ResistAid 4.5 g/day for 12 weeks during cold season in healthy adults.

199 healthy adults during cold season.

23% fewer cold episodes in ResistAid group vs placebo. Established cold prevention evidence.

2
ResistAid for Antibody Response

Clinical trial of ResistAid effects on pneumococcal vaccine antibody response.

Adults receiving pneumococcal vaccine.

Enhanced antibody response to vaccine in ResistAid group. Established adaptive immunity support.

3
ResistAid Gut Microbiome Study

Recent study on ResistAid's effects on gut microbiome composition and immune markers.

Healthy adults.

Positive modulation of gut microbiome; increased beneficial bacteria; supportive immune markers.

Side effects and drug interactions

Common Potential side effects

Generally extremely well-tolerated.
Mild GI distress (gas, bloating) at high doses — typical of soluble fiber adjustment.
Allergic reactions to larch rare.
Self-affirmed GRAS status.

Important Drug interactions

Generally minimal drug interactions.
Immunosuppressants — theoretical concern with immune-activating ingredients; consult.
Antibiotics — generally complementary; may help restore gut microbiome after antibiotic courses.
Pregnancy — generally considered safe; limited specific data.
Lactation — generally considered safe.
Children — safe at appropriate proportional doses; ResistAid studied in pediatric immune support.

Frequently asked questions about ResistAid® (Larch Arabinogalactan — Lonza)

What is ResistAid?

ResistAid® is a standardized larch arabinogalactan ingredient developed by Lonza — sustainably-sourced from North American larch trees (Larix occidentalis) using a water-based extraction method.

What is ResistAid used for?

ResistAid is researched primarily for Immune Support and Gut Health. Multiple ResistAid RCTs show reduced incidence of cold and flu symptoms in healthy adults. Riede 2013 (Curr Med Res Opin) showed 23% fewer cold episodes in ResistAid group vs placebo.

What is the recommended dosage of ResistAid?

The clinically studied dose is 1.5-4.5 g/day ResistAid (research-validated) Always follow the product label and check with a healthcare provider for personal advice.

Is ResistAid safe, and does it have side effects?

For most healthy adults, ResistAid is well tolerated at studied doses. Reported effects can include: Generally extremely well-tolerated. Mild GI distress (gas, bloating) at high doses — typical of soluble fiber adjustment. It may also interact with some medications. ResistAid is not right for everyone, so check with a healthcare provider first if you are pregnant or breastfeeding, have a medical condition, or take prescription medication.

Does ResistAid interact with any medications?

Possible interactions include: Generally minimal drug interactions. Immunosuppressants — theoretical concern with immune-activating ingredients; consult. If you take prescription medication, check with a pharmacist or doctor before using it.

How strong is the scientific evidence for ResistAid?

NutraSmarts rates the evidence for ResistAid as Strong (4 out of 5). It is backed by 3 clinical trials and 3 cited references summarized on this page. A higher rating reflects more, larger, and better-designed human studies.

References(3 citations)

Evidence ratings on NutraSmarts are based on the totality of human clinical research, with emphasis on randomized controlled trials, meta-analyses, and systematic reviews. The references below directly support claims made throughout this page.

  1. Udani JK, Singh BB, Barrett ML, Singh VJ Proprietary arabinogalactan extract increases antibody response to the pneumonia vaccine: a randomized, double-blind, placebo-controlled, pilot study in healthy volunteers. Nutrition Journal. 2010;9:32. doi: 10.1186/1475-2891-9-32.PubMedUsed to support: ResistAid-specific support for the vaccine/antibody-response claim: the proprietary larch arabinogalactan (ResistAid) increased antibody response to the 23-valent pneumococcal vaccine versus placebo. Honest framing: small (n=45) pilot study and Lonza-funded; an immune-marker (antibody titer) outcome rather than fewer clinical infections, so benefit is suggestive and modest.
  2. Udani JK Immunomodulatory effects of ResistAid: A randomized, double-blind, placebo-controlled, multidose study. Journal of the American College of Nutrition. 2013;32(5):331-8. doi: 10.1080/07315724.2013.839907.PubMedUsed to support: ResistAid-specific dose-ranging support: ResistAid (1.5 or 4.5 g/day) modulated the antibody response to tetanus and influenza vaccination versus placebo in healthy adults. Honest framing: small (n=75), Lonza-funded, surrogate immune-marker outcomes; effects were selective/partial, so this backs 'immune support' modestly rather than proving reduced illness.
  3. Riede L, Grube B, Gruenwald J Larch arabinogalactan effects on reducing incidence of upper respiratory infections. Current Medical Research and Opinion. 2013;29(3):251-8. doi: 10.1185/03007995.2013.765837.PubMedUsed to support: Backs the cold/upper-respiratory-infection claim: 4.5 g/day larch arabinogalactan over 12 weeks reduced the number of participants affected by a common cold versus placebo (significant in per-protocol analysis; borderline in full set). Honest framing: generic larch arabinogalactan preparation, modest effect with borderline p-values, single trial - supportive but not definitive.